Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of an EORTC Immune Checkpoint Inhibitor-specific Quality of Life Item List: Phase 1 & 2

NCT05554432 is registered in ClinicalTrials.gov with Institut Curie as lead sponsor.

NCT NCT05554432
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05554432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of an EORTC Immune Checkpoint Inhibitor-specific Quality of Life Item List: Phase 1 & 2
Lead sponsor
Institut Curie
Phase
Observational
Overall status
Unknown status
Start date
October 12, 2022
Completion date
April 30, 2025
Enrollment
43 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, immune checkpoint inhibitor, quality of life